Evidence map›Paper›PMID 28205100›Full record

ArticleJapanese journal of radiology2017

Efficacy of oral supplemental hydration for the prevention of contrast-induced nephropathy in rats.

Tamaki Matsunami, Kazuo Hino, Rie Dosho, Sho Miyatake, Goro Ebisu, Ryohei Kuwatsuru

Abstract read
PubMed Publisher
In one paragraph

Article in Japanese journal of radiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Tamaki MatsunamiDepartment of Radiology, Juntendo University Shizuoka Hospital, Izunokuni, Japan.
Kazuo HinoOtsuka Pharmaceutical Factory, Inc., Tokushima, Japan.
Rie DoshoDepartment of Radiology, School of Medicine Juntendo University, Tokyo, Japan.
Sho MiyatakeOtsuka Pharmaceutical Factory, Inc., Tokushima, Japan.
Goro EbisuOtsuka Pharmaceutical Factory, Inc., Tokushima, Japan.
Ryohei KuwatsuruDepartment of Radiology, Graduate School of Medicine Juntendo University, 2-1-1, Hongo, Bunkyo-ku, Tokyo, 113-8421, Japan. kuwaturu@juntendo.ac.jp.ORCID http://orcid.org/0000-0003-1960-6400
Otsuka (Japan) · JPJuntendo University · JPJuntendo University Shizuoka Hospital · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo compare oral rehydration solution (ORS) with saline infusion for preventing contrast-induced nephropathy (CIN) in a rat model. MATERIALS AND

methodsAdult male Sprague-Dawley rats (310-360 g) received intravenous indomethacin (10 mg/kg), N

resultsHydration with saline prevented only the contrast-induced increase in plasma creatinine, whereas ORS prevented deleterious changes in plasma creatinine, blood urea nitrogen, and creatinine clearance as well as in urinary protein, albumin, and N-acetyl-D-glucosaminidase concentrations. Histopathologic changes noted in the CIN group were diminished in both saline and ORS groups.

conclusionBoth intravenous saline administration and oral hydration with ORS decreased the severity of CIN. Hydration with ORS was comparable to intravenous saline infusion in preventing CIN-associated abnormalities.

Indexed as

Acute Kidney InjuryAnimalsContrast MediaDisease Models, AnimalFluid TherapyIndomethacinIohexolMaleNG-Nitroarginine Methyl EsterRandom AllocationRatsRats, Sprague-DawleySodium ChlorideContrast MediaIndomethacinIohexolNG-Nitroarginine Methyl EsterSodium ChlorideContrast-induced nephropathy (CIN)Experimental animal modelKidneyOral rehydration solutionProphylaxis

Identifiers

PMID28205100
OpenAlexW2588907667

What Socratic holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.